Critical Challenges and Landmark Practice Advances in The Science and Medicine of Parkinson's Disease
Chicago, IL
Select Session
click below to choose a session for viewing for webcast help click here
Welcome and Introduction Critical Challenges In Parkinson's Disease-An Overview Early Diagnosis, Treatment Triggers, and Therapeutic Advances Where Do We Stand? Where Are We Going?
Program Chairman:
Lawrence W.
Elmer, MD, PhD
Screen and Intervene: Confirming and Acting Upon the Diagnosis of Parkinson's Disease The Importance of Early Diagnosis and Intervention — Implications for Optimizing Patient Care
Mark F.
Lew, MD, FAAN
Evidence-Based Pharmacologic Management of Progressive Motor Disability in Parkinson's Disease Initiating, Monitoring, and Sequencing Drug Therapy for PD — Monotherapy Versus Combination Strategies and Sequencing Pharmacotherapy
Lawrence W.
Elmer, MD, PhD
Pharmacologic Issues in Drug Selection for Parkinson's Disease Selectivity versus Non-Selectivity: What Do The Trials and Evidence Teach Us?
Andrew D.
Siderowf, MD, MSCE
Management of Non-Motor Symptoms and Cognitive Complications in Parkinson's Disease Addressing the Co-morbid Challenges of Depression, and Dementia — A Glimpse Into Near Future Strategies
William G.
Ondo, MD
